Section II
2601 – 2610 of 8804
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
(
- Contribution to journal › Article
-
Mark
Acute myocardial infarction. Short-term triggers, treatment optimisation and risk stratification.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Patient registries for home oxygen research and evaluation
(
- Contribution to journal › Article
-
Mark
Kommentar till Högsta domstolens avgörande den 18 december 2018 i mål B 5050-17 (NJA 2018 s. 1051)
(
- Contribution to journal › Article
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review
-
Mark
Co-payment for unfunded additional care in publicly funded health care systems: ethical issues
(
- Contribution to journal › Article
-
Mark
God forskningssed – vad är det? Nationella och internationella riktlinjer
2019) In Acta Regiae Societatis scientiarum et litterarum Gothoburgensis. Interdisciplinaria p.19-30(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
The impact of (bio)ethics on public policies.
2019) p.205-222(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Vad göra när vi önskar att vi visste mer? En etisk fråga för socialtjänst och forskning
2019) p.43-54(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Subparalyzing Doses of Rocuronium Reduce Muscular Endurance without Detectable Effect on Single Twitch Height in Awake Subjects
(
- Contribution to journal › Article